Bio
Arvin Eslami, MD is a physician working in cancer immunotherapy research, with a focus on cellular therapies such as CAR-T cells and tumor-infiltrating lymphocytes (TILs). His interests center on clinical and translational immunology, particularly how patient-level data and immune-related factors inform treatment response and toxicity.
Current Role at Stanford
Research Associate in the Division of Immunology & Rheumatology at Stanford University School of Medicine.
Responsibilities include supporting immunotherapy and cellular therapy research (CAR-T and TIL), clinical data organization, database management, and contribution to manuscripts, systematic reviews, and meta-analyses.
July 2025 – Present
